ZAHRADKAR: nelze si patentovat výrobu? (přes nějaký bakterie třeba)? určitě by šlo napsat zákon, že ilegální budou houby a v terapii legalizovat jen "hodnej" psilocybin, nebo nejaky jeho derivat?
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
https://patents.google.com/patent/US10519175B2/enOne of the core challenges in psychedelic medicine is the high cost of delivery. Many psychedelic therapies require administration in controlled clinical environments, combined with extensive psychological support before and after dosing. This makes treatments resource-intensive and limits scalability.
To address this, companies are exploring second-generation psychedelics designed to shorten session duration, reduce hallucinatory effects, or minimise reliance on therapists. One example is tabernanthalog, a non-hallucinogenic and non-toxic analogue of ibogaine engineered to retain therapeutic potential.
Psychedelic Patents Explained: Manufacturing & Novel Compoundshttps://prohibitionpartners.com/2025/12/18/patents-and-intellectual-property-in-psychedelic-medicine-psych-the-psychedelics-as-medicine-report-3rd-edition/